Use of ganciclovir plus cytomegalovirus immune globulin to treat CMV pneumonia in orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG-Study Group.

George, M J; Snydman, D R; Werner, B G; Dougherty, N N; Griffith, J; Rohrer, R H; Freeman, R; Jenkins, R; Lewis, W D

George, M J; Snydman, D R; Werner, B G; Dougherty, N N; Griffith, J; Rohrer, R H; Freeman, R; Jenkins, R; Lewis, W D.

Affiliation

George MJ; Department of Medicine, New England Medical Center, Boston, MA 02111.

Transplant Proc ; 25(5 Suppl 4): 22-4, 1993 Oct.

Article in En | MEDLINE | ID: mdl-8212303

Subject(s)

Cytomegalovirus Infections/therapy; Ganciclovir/therapeutic use; Liver Transplantation; Pneumonia/therapy; Adult; Double-Blind Method; Humans; Immunization, Passive; Prospective Studies; Risk Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia / Ganciclovir / Liver Transplantation / Cytomegalovirus Infections Type of study: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Transplant Proc Year: 1993 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links